 Connection
Jeffrey Olsen to Carcinoma, Hepatocellular
This is a "connection" page, showing publications Jeffrey Olsen has written about Carcinoma, Hepatocellular.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
1.522 |
|
|
|
-
Olsen JR, Schefter TE. SBRT as a Favored Ablative Therapy for Stage I HCC. Int J Radiat Oncol Biol Phys. 2018 12 01; 102(5):1406.
Score: 0.566
-
Olsen JR, Murphy JD, Hallemeier CL, Apisarnthanarax S, Huguet F, Jabbour SK. Cross-Modality Comparisons Between Radiofrequency Ablation and Stereotactic Body Radiotherapy for Treatment of Hepatocellular Carcinoma: Limitations of the National Cancer Database. J Clin Oncol. 2018 08 20; 36(24):2564-2565.
Score: 0.550
-
Hallemeier CL, Olsen JR, Murphy JD, Tait D, Apisarnthanarax S, Huguet F, Jabbour SK. Gastrointestinal Cancers: Management of Rectal, Hepatocellular, Pancreatic, and Esophageal Cancers. Int J Radiat Oncol Biol Phys. 2019 05 01; 104(1):1-9.
Score: 0.146
-
Gui B, Weiner AA, Nosher J, Lu SE, Foltz GM, Hasan O, Kim SK, Gendel V, Mani NB, Carpizo DR, Saad NE, Kennedy TJ, Zuckerman DA, Olsen JR, Parikh PJ, Jabbour SK. Assessment of the Albumin-Bilirubin (ALBI) Grade as a Prognostic Indicator for Hepatocellular Carcinoma Patients Treated With Radioembolization. Am J Clin Oncol. 2018 09; 41(9):861-866.
Score: 0.139
-
Cai B, Altman MB, Garcia-Ramirez J, LaBrash J, Goddu SM, Mutic S, Parikh PJ, Olsen JR, Saad N, Zoberi JE. Process improvement for the safe delivery of multidisciplinary-executed treatments-A case in Y-90 microspheres therapy. Brachytherapy. 2017 Jan - Feb; 16(1):236-244.
Score: 0.121
|
Connection Strength
The connection strength for concepts is the sum of the scores for each matching publication.
Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.
|